print back
Consobiomed S.c.r.l.

Do you want to print an overview or a detailed profile?

Address

Piazza G.Marconi, 23

(Emilia-Romagna)

Telephone

+39 0535 24351

Fax

+39 0535 27612

World Wide Web

www.consobiomed.it

 


Overview

President:
Ing. Luciano Fecondini
Contact:
Monica Terrieri
Email:
info@consobiomed.it

Main points

CONSOBIOMED is active as an adviser in the following segments: quality assurance, legislation and standards, dealings and contacts with authorities and associations, control of production areas and advanced and further training.
The consortium companies offer both a comprehensive services package and also wide-ranging possiblities for development and production of medicinal devices and accessories, e.g:
– Design and production of medicinal one-way devices for:
anaesthesia, cardiosurgery, gynaecology, haemodialysis, haemofiltration, infusion, medication kits, mesotherapy, radiology, urology, wound stitches and endoscopic surgery
Electrosurgery, ophtalmology, othology, custom kits, rinse sets, filters of polysulphone
– Design and production of electromedicinal devices for:
Intensive therapies, urodynamic intensive therapies, cavernosometry, gastrointestinal motility, vestibology and rhinomanometry
– Design and production of machines for the automatic compostion of of medicinal products and tests
– Packaging material for individual devices
– Sterilisation by ethyloxide and radiation
– Working in clean rooms (clean room as per ISO 7 and ISO 8)
– Design of tools
– Forming and pressing

Brief description

MIRANDOLA is an industrial and agricultural centre 30 km north of Modena. Here a successful biomedicinal industry has been developed since 1964, the beginnings of which lay in the specialisation of one-way plastic products for dialysis, plasmapheresis and transfusion and infusion therapies. In the field of these innovative technologies, the activities were extended to include the design and manufacturer of machines.
The naming of the district 'Plastic Valley' was directed thererby at the Califorinain 'Silicon Valley'.
Multinational groups such as Diedeco, Bellco, Sorin, Gambro, Tyco Mallinckrodt, Fresenius or B.Braun made a signficant contribution to the build-up of this industrial sector in that these companies,attracted by the technological potential of the region, set up business here and took over already existing firms.
With the establishment of important industrial companies since the middle of the 1970s, an own production culture has been developed, which again led to the foundation of numerous small production and services companies in the biomedicine field. CONSOBIOMED was founded in 1990 in Mirandola and is a merger of many of the companies located there. Initially the main task area of CONSOBIOMED was restricted to assisting the SMEs in the branch with questions concering European standards and quality seals. In the interim, CONSOBIOMED coordinates and supports also the companies in trading with asscoiatied companies.

Initially, what applied was the taking into consideration in produktion of international quality standards and precise statutory provisions. Stimulation was given by the cooperation between various small companies in order jointly to provide services, among them consutling for qualtiy assurance systems and branch-related laws and standards, dealings and contacts with administrative authorities, controls in the production areas and advanced and further training.

After receiving its authorisation, the merged companies began to concentrate on marketing. In 1999 CONSOBIOMED was transformed into a consortium for foreign trade with its emphasis on the internationalisation of the district. The following activites were gvien precedence: participation in Trade Fairs, advertising, research, organisation and conduct of conferences, international business journeys and delegations. Today the consortium consists of firms with a high technological competence level and dynamic, flexible production capacities. These concern the whole production cycle of medicinal devices, from the production of the individual components through to the sterile commercial product.

Companies:
30